Skin rash associated with atazanavir: Report of three cases [1]

AIDS

Volumn 20, Issue 8, 2006, Pages 1207-1208

  Ouagari, Zineb ^a   Tubiana, Roland ^a   Mohand, Hocine Ait ^a   Dominguez, Stephanie ^a   Duvivier, Claudine ^a   Bricaire, François ^a   Katlama, Christine ^a   Caumes, Eric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG ERUPTION; DRUG WITHDRAWAL; DRY SKIN; ERYTHEMA; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LETTER; MACULOPAPULAR RASH; MALE; NAIL DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; TOE; TREATMENT OUTCOME;

ADULT; DRUG ERUPTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; OLIGOPEPTIDES; PYRIDINES;

EID: 33646863923     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000226965.17966.3c     Document Type: Letter

References (1)

1. Musial BL, Chojnacki JK, Coleman GI. Atazanavir: a new protease inhibitor to treat HIV infection. Am J Health-Syst Pharm 2004; 61:1365-1373.